((3S,4R,5R)-3-(benzyloxy)-4,5-dihydroxy-6-oxocyclohex-1-enyl)methyl acetate

ID: ALA1938630

Chembl Id: CHEMBL1938630

Max Phase: Preclinical

Molecular Formula: C16H18O6

Molecular Weight: 306.31

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)OCC1=C[C@H](OCc2ccccc2)[C@H](O)[C@@H](O)C1=O

Standard InChI:  InChI=1S/C16H18O6/c1-10(17)21-9-12-7-13(15(19)16(20)14(12)18)22-8-11-5-3-2-4-6-11/h2-7,13,15-16,19-20H,8-9H2,1H3/t13-,15-,16-/m0/s1

Standard InChI Key:  XNLQDMMJSVOLLD-BPUTZDHNSA-N

Alternative Forms

  1. Parent:

    ALA1938630

    ---

Associated Targets(Human)

GSTA2 Tbio Glutathione S-transferase A2 (52 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GSTM1 Tbio Glutathione S-transferase Mu 1 (61 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GSTP1 Tchem Glutathione S-transferase Pi (449 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 306.31Molecular Weight (Monoisotopic): 306.1103AlogP: 0.37#Rotatable Bonds: 5
Polar Surface Area: 93.06Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 12.24CX Basic pKa: CX LogP: 0.54CX LogD: 0.54
Aromatic Rings: 1Heavy Atoms: 22QED Weighted: 0.76Np Likeness Score: 1.29

References

1. Wang CH, Wu HT, Cheng HM, Yen TJ, Lu IH, Chang HC, Jao SC, Shing TK, Li WS..  (2011)  Inhibition of glutathione S-transferase M1 by new gabosine analogues is essential for overcoming cisplatin resistance in lung cancer cells.,  54  (24): [PMID:22085405] [10.1021/jm201131n]

Source